High Testosterone Test Female 42 Tired PCOS: What Your Lab May Have Missed

Most hospital and Quest/LabCorp panels use chemiluminescent immunoassays (CLIA) to measure total testosterone. These assays were designed and validated in men, where testosterone circulates at 300–1000 ng/dL. In women—especially those in perimenopause or with PCOS—testosterone typically ranges from 15–70 ng/dL, well below the assay's reliable detection threshold.

CLIA methods use antibodies that bind to testosterone, but those antibodies aren't perfectly selective. They cross-react with structurally similar molecules: DHEA-S (often elevated in PCOS), androstenedione, and even some estrogen precursors. The result is a falsely elevated reading. A study in the Journal of Clinical Endocrinology & Metabolism found that immunoassays overestimated female testosterone by 20–40% compared to LC-MS/MS in women with PCOS.

This matters enormously when you're trying to understand why you're tired. If your testosterone isn't actually high, the fatigue has a different root—often low free T3 thyroid hormone, iron deficiency, or the metabolic insulin resistance that drives PCOS itself. We've seen women in Oak Brook and Barrington spend months chasing androgen suppression with spironolactone or metformin, only to discover their true testosterone was normal once we ran LC-MS/MS confirmation.

PCOS is classically defined by hyperandrogenism—elevated testosterone or DHEA-S, irregular cycles, and often insulin resistance. Yet many women with biochemically confirmed high androgens still report debilitating fatigue, not the energy surge you'd expect from elevated testosterone.

The explanation lies in what else is happening metabolically. Insulin resistance—the core driver in most PCOS cases—impairs mitochondrial function and glucose delivery into cells, leaving you energy-starved despite normal or high blood sugar. Chronic low-grade inflammation from visceral adiposity (which we measure with DEXA scans for visceral fat) further suppresses cellular energy production. Meanwhile, high androgens can suppress thyroid hormone conversion (T4 to active T3) and disrupt sleep architecture, compounding fatigue.

In our practice, we see this pattern frequently in women in their early 40s: testosterone 90 ng/dL on immunoassay, fasting insulin 18 µIU/mL (should be <7), free T3 in the low-normal range (2.5 pg/mL; optimal >3.0), and ferritin 25 ng/mL (functional threshold >50). The testosterone number grabs attention, but it's rarely the primary cause of the fatigue.

Key metabolic contributors to fatigue in PCOS:

Factor	Mechanism	Typical Lab Finding
Insulin resistance	Impaired glucose uptake, mitochondrial dysfunction	Fasting insulin >10 µIU/mL, HOMA-IR >2.0
Thyroid conversion block	High androgens inhibit 5'-deiodinase	Free T3 <3.0 pg/mL despite normal TSH
Iron deficiency	Reduced oxygen transport, fatigue independent of anemia	Ferritin <50 ng/mL
Chronic inflammation	Elevated IL-6, TNF-α suppress energy production	hs-CRP >1.0 mg/L

You should question your testosterone result if:

1. The number seems high but your symptoms don't match. True androgen excess typically causes hirsutism (coarse facial/body hair), acne, scalp hair thinning, and increased libido—not fatigue and brain fog.
2. Your test was run on a standard hospital or commercial lab panel. If the lab report doesn't specify "LC-MS/MS" or "mass spectrometry," assume it's an immunoassay.
3. You're perimenopausal (typically starting age 38–45). Estrogen fluctuations during this transition interfere with immunoassay antibodies, increasing false-positive rates.
4. Your DHEA-S is also elevated. DHEA-S >350 µg/dL can cross-react on testosterone immunoassays, artificially inflating the result.

In these scenarios, we retest using LC-MS/MS. This method physically separates testosterone from other molecules using liquid chromatography, then identifies it by molecular weight with tandem mass spectrometry. It's accurate down to 1 ng/dL and is the only method endorsed by the Endocrine Society for diagnosing androgen disorders in women.

Quest and LabCorp both offer LC-MS/MS testosterone panels (order code "Testosterone, Total, LC-MS/MS, Female" at Quest; "Testosterone, Total MS" at LabCorp). Turnaround is 3–5 days, and cost is typically $75–150 if not covered by insurance. We routinely order this for our patients in Naperville and across the northwest suburbs when initial results don't align with clinical presentation.

To definitively assess androgen status in a woman with PCOS and fatigue, we order:

1. Total testosterone by LC-MS/MS
Normal range 15–70 ng/dL; >70 ng/dL suggests true hyperandrogenism if confirmed by mass spec.

2. Free testosterone (calculated or by equilibrium dialysis)
Bioavailable testosterone matters more than total. We calculate free T using total testosterone, SHBG, and albumin. Normal free T in women is 0.3–1.9 pg/mL; >2.5 pg/mL is significant.

3. SHBG (sex hormone–binding globulin)
Insulin resistance suppresses SHBG, increasing free testosterone even when total T is normal. SHBG <30 nmol/L is common in PCOS and raises free androgen index.

4. DHEA-S
Elevated DHEA-S (>350 µg/dL) points to adrenal androgen excess, common in PCOS, and can cross-react on immunoassays.

5. Androstenedione
Often elevated in PCOS (>3.0 ng/mL); another source of immunoassay interference.

We also measure fasting insulin, hemoglobin A1c, free T3, ferritin, and hs-CRP to identify the metabolic and inflammatory drivers of fatigue that coexist with—but are distinct from—androgen excess. This comprehensive panel, interpreted in the context of symptoms and body composition, guides our treatment strategy far more effectively than a single testosterone number.

If LC-MS/MS confirms truly elevated testosterone (>70 ng/dL total or >2.5 pg/mL free), the next question is why—and whether it's the primary cause of your fatigue.

Step 1: Rule out non-PCOS causes

• Late-onset congenital adrenal hyperplasia (check 17-hydroxyprogesterone)
• Androgen-secreting tumor (rare; suspect if testosterone >150 ng/dL or rapid onset)
• Exogenous androgen exposure (supplements, compounded hormones)

Step 2: Address insulin resistance first
In our experience, improving insulin sensitivity—through time-restricted eating, resistance training, and when appropriate, metformin or GLP-1 agonists—often resolves fatigue even when testosterone remains mildly elevated. Target fasting insulin <7 µIU/mL and HOMA-IR <1.5.

Step 3: Optimize thyroid and micronutrients
Free T3 should be >3.0 pg/mL; ferritin >50 ng/mL (ideally 80–100); vitamin D >40 ng/mL. These are low-hanging fruit that dramatically improve energy independent of androgen status.

Step 4: Consider androgen modulation only if hyperandrogenism is confirmed and symptomatic
Spironolactone (25–100 mg daily) blocks the androgen receptor and can reduce hirsutism and acne, but it doesn't reliably improve fatigue. Metformin (1000–2000 mg daily) lowers androgens indirectly by improving insulin sensitivity. We rarely use anti-androgens as first-line fatigue treatment.

Step 5: Monitor cardiovascular and metabolic risk
PCOS increases lifetime risk of type 2 diabetes and cardiovascular disease. We track ApoB (goal <80 mg/dL), Lp(a), coronary artery calcium score, and VO₂ max as part of our Medicine 3.0 preventive approach, treating PCOS as a metabolic disease, not just a reproductive one.

If confirmatory LC-MS/MS testing shows your testosterone is actually normal or only mildly elevated, the fatigue has a different origin. In women in their early 40s, we systematically evaluate:

Perimenopause and progesterone deficiency
Anovulatory cycles (common in PCOS) mean no corpus luteum and no progesterone. Low progesterone disrupts sleep, causing unrefreshing rest and daytime fatigue. We measure progesterone on cycle day 21 (or randomly if cycles are irregular); <3 ng/mL suggests anovulation.

Subclinical hypothyroidism or poor T4→T3 conversion
TSH may be normal (0.5–4.0 µIU/mL), but free T3 in the low-normal range (<3.0 pg/mL) is insufficient for optimal energy. Reverse T3 elevation (>20 ng/dL) indicates conversion block from inflammation or caloric restriction.

Iron deficiency without anemia
Ferritin <50 ng/mL impairs mitochondrial function and oxygen delivery even when hemoglobin is normal. We replicate iron to >80 ng/mL and see energy improve within 6–8 weeks.

Mitochondrial dysfunction and low NAD+
Chronic stress, poor sleep, and insulin resistance all impair mitochondrial ATP production. We assess indirectly via lactate, VO₂ max (see our discussion of VO₂ max benchmarks at age 48), and response to NAD+ precursors (NMN or NR).

Sleep apnea
PCOS increases risk of obstructive sleep apnea due to visceral adiposity and androgen effects on upper airway. Home sleep study (WatchPAT) is a low-barrier screening tool we use frequently.

Each of these is addressable with targeted intervention—but only if we look beyond the testosterone number and take a systems-based diagnostic approach.